A well-known injectable birth control method is under fire after multiple studies linked it to a specific kind of brain tumor, and now, lawsuits are piling up against the drugmaker. […] The post ...

The hormonal treatments cyproterone acetate and medroxyprogesterone acetate are the most effective at reducing hot flushes, a common side-effect in men being treated with hormone therapy for ...

Use of the injectable contraceptive depot medroxyprogesterone acetate (MPA), common in areas such as sub-Saharan Africa with high HIV-1 prevalence, is associated with suppression of the immune ...

A new study has linked a type of injectable birth control with meningioma. The manufacturer says the claims are “without ...

Medroxyprogesterone acetate - a castrating agentMedroxyprogesterone acetate (MPA) is one among the several medicines that have been used for chemical castration for sex offenders. This drug is mainly ...

Sixty patients were entered (thalidomide:medroxyprogesterone = 29:31; median age, 59 [thalidomide], 60 [medroxyprogesterone]; No. of patients assessable for response, 22 [thalidomide], 26 ...

PURPOSE: Progestins have definite activity against advanced or recurrent endometrial carcinoma. Both parenteral and oral progestins yield similar serum levels and response rates, which range from 18% ...

Send press releases and comments to news@medscape.net. Cite this: Depot Medroxyprogesterone Acetate Associated With Fracture Risk in Young Women - Medscape - Sep 16, 2009.

Men with prostate cancer who reported having significant hot flushes during androgen suppression treatment had a better hormonal response with cyproterone and medroxyprogesterone compared with ...

New research suggests that use of depot medroxyprogesterone acetate may be associated with an increased risk for fracture in women, particularly in those with longer treatment duration and ...